Physicochemical characterisation of a novel thermogelling formulation for percutaneous penetration of 5-aminolevulinic acid.
The present contribution was dedicated to the development and characterisation of a semisolid formulation of 5-aminolevulinic acid (5-ALA), appropriate for the diagnosis and treatment of actinic keratosis in photodynamic therapy. To achieve sufficiently high concentrations of the polar substance within the living epithelium after topical application, the semisolid base was enriched with penetration enhancers. A semisolid liquid crystalline system for drug delivering was the formulation of choice. It was composed of isopropyl alcohol, dimethyl isosorbide, medium chain triglycerides, water, and Pluronic F 127 as a polyoxyethylene-polyoxypropylene surface-active block copolymer. Rheometrical investigations were performed in the oscillatory mode and showed a thermo reversible gelification behaviour of the formulation, which therefore was denoted Thermogel. Permeation studies through human stratum corneum revealed higher permeation coefficients for 5-ALA from the Thermogel than from different German Pharmacopoeia creams. For example a 7.5-fold increase in comparison with Basiscreme DAC, and a 19.5-fold increase compared to water containing hydrophilic ointment. With respect to Dolgit(R) Mikrogel, the permeation coefficient from the Thermogel was 6.4-fold higher. These results were in accordance with those of differential scanning calorimetry measurements. Thermogel disclosed the strongest interactions with stratum corneum lipids.
Grüning
Nadja
N
Technical University of Braunschweig, Institute of Pharmaceutical Technology, Mendelssohnstrasse 1, 38106 Braunschweig, Germany.
Müller-Goymann
Christel Charlotte
CC
D019840:2-Propanol / Q000737:chemistry; D000279:Administration, Cutaneous; D000622:Aminolevulinic Acid / Q000008:administration & dosage / Q000737:chemistry / Q000378:metabolism*; D002152:Calorimetry, Differential Scanning; D002626:Chemistry, Pharmaceutical; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000737:chemistry / Q000378:metabolism*; D004337:Drug Carriers; D004339:Drug Compounding; D005260:Female; D005782:Gels; D006801:Humans; D007547:Isosorbide / Q000031:analogs & derivatives / Q000737:chemistry; D007700:Kinetics; D050866:Liquid Crystals; D008875:Middle Aged; D009824:Ointments; D010539:Permeability; D020442:Poloxamer / Q000737:chemistry; D012212:Rheology; D012869:Skin Absorption; D013678:Technology, Pharmaceutical / Q000379:methods; D013696:Temperature; D014280:Triglycerides / Q000737:chemistry; D014867:Water / Q000737:chemistry